• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec16
Keji Pharmaceutical-B repurchased 1,010,000 shares for HKD14.762 million
13:53
Dec11
Keji Pharmaceutical-B Repurchased 1,020,000 Shares
12:16
Guo Huaqing Reduced 10,000 Shares of Keji Pharmaceutical
11:10
Dec1
Keji Pharmaceuticals-B Repurchased 173,500 Shares
13:46
Nov25
Non-executive Director Guo Huaqing Buys Shares in Celltrion
11:05
Nov24
Keji Pharmaceutical-B Repurchased 360,000 Shares for HKD 5.9567 Million
11:24

Schedules & Filings

Schedules
Filings
Aug14
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 27.89 M, Net Income -41.31 M, EPS -0.0749

Mar18
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 17.6 M, Net Income -237.54 M, EPS -0.4329

Aug28
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 3.406 M, Net Income -188.88 M, EPS -0.339

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
08423
0.064
+68.42%
+0.026
01233
0.149
+39.25%
+0.042
01163
0.176
+37.50%
+0.048
06038
0.310
+34.78%
+0.080
00475
0.490
+27.27%
+0.105
06893
0.300
+25.52%
+0.061
01842
0.051
+24.39%
+0.010
08429
0.053
+23.26%
+0.010
06869
46.520
+21.21%
+8.140
01631
0.475
+20.25%
+0.080
View More